Clinical trial

Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes

NCT03961217

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

RADIATION · Unmapped registry intervention Radiotherapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date1991-01-01

PhaseN/A

Conditions

Gynecologic Cancerverified · MONDO: female reproductive organ cancer

Prostate Cancerverified · MONDO: prostate cancer

Radiation Toxicityunresolved

Malignancyverified · MONDO: cancer

Radiotherapy Side Effectunresolved

Radiation Injuriesunresolved

Cancer Survivorsunresolved

Radiation Syndromeunresolved

Interventions

RadiotherapyRADIATION

Sponsors & collaborators

Sahlgrenska University Hospitallead sponsor

Vastra Gotaland Regioncollaborator

Mapped research locations

GothenburgSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03961217 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.